Home / Research and experimental development on medical and veterinary sciences
ROFFE INTERNATIONAL HOLDINGS PTE. LTD.
ROFFE INTERNATIONAL HOLDINGS PTE. LTD. is a local company in Singapore with UEN 202004824Z. It was registered on 11 Feb 2020, 6 years ago. Its status is Live Company. Its main activity is research and experimental development on medical and veterinary sciences.
| UEN | 202004824Z |
|---|---|
| Status | Live Company |
| Entity type | Local Company, Exempt Private Company Limited by Shares |
| Registered | 11 Feb 2020 |
| Main activity (SSIC) | 72106 Research and experimental development on medical and veterinary sciences |
| Secondary activity | 32501 Manufacture of medical research and clinical diagnostic instruments and supplies |
| Address | 585 NORTH BRIDGE ROAD, #01-02, RAFFLES HOSPITAL, Singapore 188770 54 companies at this address |
| Area | Downtown Core · District 7 (Middle Road, Golden Mile) |
| Nearest station | Bugis MRT, about 133 m |
| Officers | 13 |
| Last annual return | 11 Jul 2025 |
Government contracts
One contract awarded through GeBIZ, SGD 8,462 in total. Awards from 1 Apr 2021 to 31 Mar 2026, matched by company name.
| 30 Mar 2026 | Tender for Term Contract for the Supply and Delivery of Nursing Medical Consumables Pls note there will be a non-mandatory online Tender Briefing on 19 Sep 2025 at 10am. Refer to "Site Brief Info" section. Interested Tenderers are to complete & upload the following Tender Documents in the final submission 1) Part 6 - Documents for Tender Submission 2) Annex A_Specifications_Compliance Declaration and Price Schedule for Medical Consumables 3) Annex B_Proposed Product Photo Submission Nanyang Polytechnic · SGD 8,462 · NYP000ETT25000030 |
|---|
Newer companies in research and experimental development on medical and veterinary sciences
- GTTNANO PTE. LTD.
- BLUE RIBBON BIOTECHNOLOGY PTE. LTD.
- XINYEN BIOMEDICAL PTE. LTD.
- HJ SCIENCE SINGAPORE PTE. LTD.
- ARCHEON THERAPEUTICS PTE. LTD.
- KCY CONSULTING AND STUDIO
Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.